Cite
HARVARD Citation
Vasan, N. et al. (2014). A Targeted Next‐Generation Sequencing Assay Detects a High Frequency of Therapeutically Targetable Alterations in Primary and Metastatic Breast Cancers: Implications for Clinical Practice. Oncologist. pp. 453-458. [Online].